Imagion Biosystems Ltd has released a press release.
Imagion Biosystems: Half Yearly Report and Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
Imagion Biosystems Ltd. on 6ix
Earlier from Imagion Biosystems
- Variation of Convertible Securities Agreement
- Reinstatement to Quotation
- Imagion appoints new Non-Executive Director
- Prospectus - Convertible Notes
- Suspension from Quotation
Later from Imagion Biosystems
- Response to ASX Price Query
- Successful Placement of A$3M
- Quarterly Activities/Appendix 4C Cash Flow Report
- Imagion Initiates Manufacturing of Drug for Phase 2 Study
- Appendix 4E and 2024 Financial Report
Follow Imagion Biosystems into a list and get an email when it puts out news.
Follow Imagion Biosystems